Type 1 diabetes: treatment [sounds like]
409 results
201 - 300
Sulphonylurea for type 2 diabetes 
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy- Unintentional weight loss in adults
- Lifestyle interventions for the treatment of women with gestational diabetes
- Insulin for the treatment of women with gestational diabetes
- Spinal cord stimulation for chronic pain: Cochrane systematic review
- Treatment of lower extremity ulcers
- Dipeptidyl‐peptidase (DPP)‐4 inhibitors and glucagon‐like peptide (GLP)‐1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus
- Prevention of type 2 diabetes in persons at increased risk for the development of T2D
- Sodium‐glucose co‐transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes
- Colesevelam for type 2 diabetes mellitus
- Prevention of type 2 diabetes by life-style changes
Intensive glucose control ineffective in ICU patients- Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes
- Relaxed hemoglobin A1c goals for T2DM from the American College of Physicians
- Uncertain if tight control reduces long-term mortality in patients with T1DM
- Gestational diabetes mellitus and future risk of diabetes
- Scoliosis and kyphosis
- Diagnosis and treatment of childhood hypercholesterolaemia
- Continuous glucose monitoring systems for type 1 diabetes mellitus
- Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control
- Secondary hypertension
- Dressings for healing diabetic foot ulcers
- Diabetic kidney disease (diabetic nephropathy)
- Low glycaemic index, or low glycaemic load, diets for diabetes mellitus
- Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings
- Pentoxifylline for diabetic kidney disease
- Newer hypoglycemics don't increase or decrease mortality
- Growth factors for treating diabetic foot ulcers
- Finerenone decreases hospitalization for heart failure in patients with type 2 diabetes and chronic kidney disease (NNT = 189/year)
- Nephrotic syndrome
- Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease
- Pressure-relieving interventions for treating diabetic foot ulcers: Cochrane systematic review
- SGLT-2 inhibitors and GLP-1 agonists for diabetes and chronic kidney disease
- Foot skin problems
- Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: Cochrane systematic review
- Glucagon‐like peptide 1 (GLP‐1) receptor agonists for people with chronic kidney disease and diabetes
- Metformin minimally beneficial, if at all, when added to insulin in overweight adolescents with T1DM
- Diabetes as a risk factor for tuberculosis disease
- Primary Sjögren's syndrome
- Chronic diseases and pregnancy
- Intra-articular more effective than oral steroids for adhesive capsulitis
- Different strategies for diagnosing gestational diabetes to improve maternal and infant health
- Gout and pseudogout
- Systemic antibiotics for treating diabetic foot infections
- Treatment of chronic renal failure
- Prolonged diarrhoea in adults
- Conservative (non-surgical) treatment of obesity
- Psychological interventions for parents of children and adolescents with chronic illness
- Topical antimicrobial agents for treating foot ulcers in people with diabetes
- Antihypertensive therapy beneficial for patients with BP < 140/90 and history of CVD
- Vitamin B and its derivatives for diabetic kidney disease: Cochrane systematic review
- Interventions for latent autoimmune diabetes (LADA) in adults: Cochrane systematic review
- Lifestyle changes in women with polycystic ovary syndrome
- Insulin versus oral anti-diabetic pharmacological therapies for gestational diabetes
- Different lasers and techniques for proliferative diabetic retinopathy: Cochrane systematic review
- Treatment of dyslipidaemias
- GLP‐1 receptor agonists for Parkinson's disease
- Different insulin types and regimens for pregnant women with pre‐existing diabetes
- Pine bark (Pinus spp.) extract for treating chronic disorders
- Intensive weight management for remission of type 2 diabetes
- Interventions for people with type 2 diabetes mellitus fasting during Ramadan
- (Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus
- Overweight and obesity in children
- Similar long-term morbidity and mortality with human insulin and analogue insulins
- Statins for dialysis patients
- Fetal biometry for guiding the medical management of women with gestational diabetes mellitus for improving maternal and perinatal health
- Abnormal screening glucose challenge test in pregnancy and future risk of diabetes
- Darbepoetin alfa minimally effective, increases stroke risk in diabetic nephropathy
- Gabapentin for chronic neuropathic pain in adults
- Statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests
- Rosiglitazone more likely to succeed as monotherapy but POEMs lacking
- Tight glycemic control may decrease CV end points in patients with type 2 DM
- Surgery for morbid obesity
- Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus
- Effective strategies for the prevention of preeclampsia and pregnancy-induced hypertension
- SBP of 120 instead of 140 in adults 75 years or older = significant benefits and some harms (SPRINT)
- Risk of lactic acidosis with metformin in type 2 diabetes
- Mediterranean diet reduces cardiovascular events (PREDIMED)
- Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease: a network meta‐analysis
- Liraglutide produces modest weight loss and lots of side effects at a high cost
- Treatments for gestational diabetes: Cochrane systematic review
- Sulfonylurea drugs for people with severe hemispheric ischemic stroke
- Antibiotic prophylaxis for mammalian bites: Cochrane systematic review
- Dressings and topical agents containing hyaluronic acid for chronic wound healing
- PCOS symptoms in adolescents: no good guidance
- Low‐carbohydrate versus balanced‐carbohydrate diets for reducing weight and cardiovascular risk
- Pregabalin for neuropathic pain in adults
- Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
- Assessing a patient with an abnormal liver function test result
- Antenatal clinics: care and examinations
- Glucose targets for preventing diabetic kidney disease and its progression
- Efficacy and safety of cholesterol lowering by statins
- Lifestyle interventions for the treatment of women with gestational diabetes
- Endoscopic sphincterotomy for adults with biliary sphincter of Oddi dysfunction
- Interventions in the treatment and prevention of obesity
- Monotherapy laser photocoagulation for diabetic macular oedema